• Vol. 42 No. 9, 480–482
  • 15 September 2013

Trends Amongst Implantable Cardioverter Defibrillator Patients in a Tertiary Cardiac Centre in Singapore from 2002 to 2011

40



Implantable cardioverter defibrillators (ICDs) are established therapy for cardiac patients at significant increased risk of sudden cardiac death. The relative risk reduction in mortality range from 23% at 5 years for primary prevention patients in the SCD-HeFT trial to 39% at one year for the secondary prevention patients in the AVID trial.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.